Abstract
Hodgkin lymphoma (HL) is a curable malignancy with excellent long-term survival, shifting the focus of care toward survivorship challenges, including mental and functional health. This population-based retrospective cohort study evaluated the incidence, timing, and risk factors for mental and functional disorders (including fibromyalgia, irritable bowel syndrome, insomnia and related conditions) among young adult HL survivors in Israel compared with age- and sex-matched controls. Data was retrieved from the electronic medical database of Maccabi Healthcare Services, encompassing 1007 young (18-50 years) HL patients, diagnosed between 1995 and 2021, and 20140 controls, with a median follow-up of 12 years.
Prior to HL diagnosis, mental or functional disorders were more prevalent among patients than controls (15.3% vs. 10.2%, p<0.001). Among HL survivors, 53% developed new-onset mental or functional complications during follow-up, compared with 33% of controls (p<0.001). Early-onset disorders (within 6 months of diagnosis) occurred 12-fold more frequently in HL survivors, most commonly anxiety, depression, opioid use, and fibromyalgia. Late-onset disorders (>6 months) were also significantly higher in HL survivors.
Multivariate analyses identified Jewish ethnicity (HR=2.24; 95% CI, 1.06-4.77; p=0.036) and cardiovascular comorbidity (HR=7; 95% CI, 1.67-29.6; p=0.008) as independent risk factors for developing mental and/or functional disorder. These findings, in a relatively large cohort, highlight a substantial and sustained risk of mental and functional health complications among HL survivors and underscore the need for systematic psychosocial screening and tailored interventions within survivorship programs to optimize long-term well-being.
Figures & Tables
Article Information

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.